Shock Wave Therapy: Do the External Appearance of the Device Influence Clinical Outcomes?
CompletedPhase 4NCT02608723
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
To check in patients suffering from chronic plantar fasciitis treated with shock wave therapy, if the outward appearance of the device affects clinical outcomes.
Study details
- Official title
- Chronic Plantar Fasciitis Treated With Shock Wave Therapy: Do the External Appearance of the Device Influence Clinical Outcomes? A Randomized Controlled Clinical Trial.
- Conditions
- Interventions
- Device: Standard shock waves device
- Device: Austere shock waves device
- Device: Sophisticated shock waves device
- Sponsor
- Asociacion Colaboracion Cochrane Iberoamericana
- Start date
- 2014-06
- Primary completion
- 2015-06
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Spain
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Age greater than 18 years. 2. Being able to understand the explanations about the potential benefits and risks of study participation. 3. Diagnosis of chronic plantar fasciitis. Proven by clinical examination: Meeting at least 2 of the following criteria: * Tenderness in the proximal insertion of the plantar fascia (area of the medial calcaneal tuberosity). * Pain during the first steps to get out of bed in the morning and / or after a period of rest time. 4. With a duration of symptoms ≥ 6 months at the time of study entry. 5. Having received conservative therapy without success, at least two treatments. Treatments may have been made isolated, combined or consecutively. Exclusion Criteria: 1. Bilateral plantar fasciitis. 2. Hiper/ hypothyroidism. 3. Diabetes mellitus. 4. Treatment with anticoagulants 5. Inflammatory diseases.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02608723